Shuxian Chen†
Jinxia Chen†Shangmei Li†
Fengbiao Guo
Aifen LiHan Wu
Jiaxuan Chen
Quanren PanShuzhen Liao
Hua-feng Liu*
Qingjun Pan*- Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China
Nowadays, with the improvements in living standards and changes in living habits, high-fat diet (HFD) has become much more common in the populations worldwide. Recent studies have shown that HFD could induce lipid accumulation, and structural and functional abnormalities, accompanied by the release of large amounts of pro-inflammatory cytokines, in proximal tubular epithelial cells (PTECs). These findings indicate that, as an emerging risk factor, PTEC injury-induced by HFD may be closely related to inflammation; however, the potential mechanisms underlying this phenomenon is still not well-known, but may involve the several inflammatory pathways, including oxidative stress-related signaling pathways, mitochondrial dysfunction, the myeloid differentiation factor 2/Toll like receptor 4 (MD2/TLR4) signaling pathway, the ERK1/2-kidney injury molecule 1 (KIM-1)-related pathway, and nuclear factor-κB (NF-κB) activation, etc., and the detailed molecular mechanisms underlying these pathways still need further investigated in the future. Based on lipid abnormalities-induced inflammation is closely related to the development and progression of chronic kidney disease (CKD), to summarize the potential mechanisms underlying HFD-induced renal proximal tubular inflammatory injury, may provide novel approaches for CKD treatment.
Introduction
Chronic kidney disease (CKD) is a non-communicable disease with a high prevalence; it eventually presents as renal fibrosis, which is characterized by glomerulosclerosis, tubular atrophy, and tubular interstitial fibrosis (TIF; Hill et al., 2016; Lv and Zhang, 2019). The prevalence of CKD was about 9.1% in the world’s population and the global mortality was up to 1.2 million in 2017 (Bikbov et al., 2020).CKD can be induced by primary and secondary glomerulonephritis, renal tubular injury, and renal vascular lesions, such as diabetic nephropathy (DN), renal tubulointerstitial disease, and ischemic nephropathy (Lin et al., 2014; Moreno et al., 2018; Dong et al., 2019). CKD is caused by various conditions, including inflammation, oxidative stress, metabolic disorders, microvascular damage, and nephron loss (Moreno et al., 2018; Meng, 2019; Rapa et al., 2019; Ding et al., 2020; Juszczak et al., 2020; Ruiz-Ortega et al., 2020); however, the molecular mechanisms of CKD pathogenesis remain unclear. It has been reported that CKD induces multiple complications, including anemia, chronic kidney disease-mineral bone disease (CKD-MBD), and cardiovascular disease, and leads to reduced quality of life and even death (Webster et al., 2017). End-stage renal disease (ESRD), which requires renal replacement therapies such as kidney transplantation and dialysis to keep patients alive, is the final stage of CKD, and causes a heavy financial burden on the patient and the society in terms of public medical resources (Wang et al., 2016). As at now, CKD morbidity and mortality are still on the rise, making it an important public health concern. However, patients with CKD respond poorly to treatment. Therefore, for the elaboration of effective treatment strategies for CKD, it is important to clarify its pathogenesis.
High-fat diet (HFD) refers to the consumption of high fat content foods; many studies have shown that HFD is negatively associated with human health (Hohos and Skaznik-Wikiel, 2017; Rohr et al., 2020; Zimmerman et al., 2021) and that HFD is positively correlated with the occurrence of many diseases, including obesity, cardiovascular disease, and nonalcoholic fatty liver disease (NAFLD; Rabinovich-Nikitin et al., 2019; Gao et al., 2020; Gong et al., 2020; Zhang et al., 2020b). Several recent studies have reported that HFD could induce renal proximal tubular injury (Szeto et al., 2016; Yamamoto et al., 2017; Xu et al., 2019), and this may be associated with the activation of inflammatory pathways (Kennedy et al., 2013). These findings indicate that HFD may cause CKD through renal proximal tubular inflammatory injury. This review summarizes the potential role of HFD in CKD pathogenesis. We hope it would provide a scaffold for further studies on CKD pathogenesis and provide a potential theoretical basis and new direction for clinical CKD treatment.
Role of Lipids in Renal Proximal Tubular Physiological Function
Renal proximal tubules are the main components of the renal tubules and play a pivotal role in reabsorption and excretion. The maintenance of lipid homeostasis is essential for renal proximal tubular physiological function (Gullans et al., 1984; Balaban and Mandel, 1988).
Lipids are the fundamental composition of cells. They present in the kidneys include triglycerides, phospholipids, cholesterol and its esters, and free fatty acids (FFAs; Hagve et al., 2001; Herman-Edelstein et al., 2014; Chen et al., 2019). In mammalian cells, FFAs are generated through the de novo synthetic pathway and released when triglycerides and phospholipids are hydrolyzed by cellular lipases (Schaffer, 2003). FFAs can also be imported into mammalian cells by both protein- and non-protein-mediated mechanisms (Schaffer, 2002). Most FFAs bind to albumin in plasma, and albumin-bound FFAs can be absorbed in the proximal tubules through receptor-mediated albumin endocytosis (Bobulescu, 2010). In addition, proximal tubular epithelial cells (PTECs) take up circulating FFAs dissociated from albumin through specific membrane proteins, such as fatty acid (FA) translocase (CD36) and FA-binding protein (Stremmel et al., 2001). These absorbed lipids are then oxidized and metabolized in PTEC mitochondria to produce ATP, thereby, maintaining energy balance in the tubules (Brunskill et al., 1997; Birn and Christensen, 2006; Kang et al., 2015; Yamamoto et al., 2021). Under physiological conditions, lipid metabolism in PTECs may protect renal tubules from damage caused by lipid overload. However, excess lipid accumulation may lead to renal tubular damage in the proximal tubules.
Dyslipidemia and Renal Proximal Tubular Injury
Dyslipidemia in CKD Patients
Dyslipidemia, which is caused by various factors, refers to the pathological accumulation of abnormal lipids and their metabolites in blood, tissues, and organs. It is characterized by the abnormal concentration of triglyceride (TG), cholesterol such as total cholesterol (TC), very-low-density lipoprotein cholesterol (VLDL-C), low-density lipoprotein cholesterol (LDL-C), intermediate-density lipoprotein cholesterol (IDL-C), and high-density lipoprotein cholesterol (HDL-C), or other lipids (Catapano et al., 2016; Kopin and Lowenstein, 2017). The dyslipidemia in CKD patients showed the elevated concentration of TG, VLDL, and IDL, the reduced concentration of HDL-C and the varied concentration of TC and LDL-C (Hager et al., 2017; Lamprea-Montealegre et al., 2018; Miljkovic et al., 2018; Bermudez-Lopez et al., 2019; Czaplińska et al., 2019). Many evidences suggested that lipids are nephrotoxic. The cholesterol levels are associated with the elevated mortality in the absence of inflammation and malnutrition in dialysis patients (Liu et al., 2004). The increased TC, non-HDL-C and the ratio of TC/HDL levels, and decreased HDL are significantly related to renal dysfunction in men with an initial creatinine <1.5 mg/dl (Schaeffner et al., 2003). Further, a Chronic Renal Insufficiency Cohort (CRIC) study showed that LDL-C and TC concentration are inversely associated with kidney disease outcomes in patients with low proteinuria levels (Rahman et al., 2014). The elevated levels of LDL receptor (LDLR), oxidized LDL (ox-LDL), acetylated LDL (acLDL), and CD-36 are significantly related to the progression of DN and deterioration of eGFR (Kiss et al., 2013; Herman-Edelstein et al., 2014). Previous studies have shown that patients with nephrotic syndrome are usually comorbid with lipid metabolic disorders characterized by elevated serum cholesterol, TG, and phospholipid levels, and decreased serum HDL levels (Joven et al., 1990; Vaziri, 2016). CKD patients with significant proteinuria may also suffer from dyslipidemia and have increased serum creatinine (Scr) levels (Agrawal et al., 2018). Renal biopsy specimens from patients with DN showed lipid deposition in renal inherent cells, especially in PTECs, as well as renal structural and functional abnormalities (Bobulescu, 2010; Kiss et al., 2013; Herman-Edelstein et al., 2014). These results confirmed that lipid accumulation in kidney is associated with abnormal renal function. Study reported that PTECs appear to be more prone to lipid accumulation than other renal inherent cells, probably due to their higher energy expenditure rate (Gai et al., 2019). Dyslipidemia in patients with CKD is associated with a deterioration of renal function (Herman-Edelstein et al., 2014). The “lipid nephrotoxicity” hypothesis proposed by Moorhead et al. (1982) stated that dyslipidemia could affect CKD progression; this hypothesis has aided our understanding of CKD progression. Recently, lipid nephrotoxicity became a significant research hotspot.
HFD-Induced Renal Proximal Tubular Injury in vivo
Lipid abnormalities are detrimental to the kidneys. A study showed that HFD alone could not induce kidney lesions (Yang et al., 2017); however, a large amount of data indicated that HFD increases lipid accumulation in proximal tubules and lipid accumulation (especially saturated fatty acid, SFA)-induced alternations in the function and structure of PTECs (Arici et al., 2003; de Vries et al., 2014; Declèves et al., 2014; Khan et al., 2014; Li et al., 2016; Yamamoto et al., 2017). These findings are summarized in Table 1.
Table 1. Relevant information on high-fat diet (HFD)-induced renal proximal tubular impairment.
Increasing evidence indicated that HFD induces an increase in cholesteryl ester and phospholipid levels in proximal tubules, and a significant elevation in Scr and blood urea nitrogen (BUN) levels, pro-inflammatory cytokines production, and kidney injury biomarker production, including the neutrophil gelatinase-associated lipocalin (NGAL), renin messenger RNA (mRNA), and kidney injury molecule 1 (KIM-1; Declèves et al., 2014; Fang et al., 2015, 2017; Cheng et al., 2019; Luo et al., 2019; Xu et al., 2019; Hewage et al., 2020). Oxidative stress, mitochondrial dysfunction, and impairment of lysosomal acidification were observed in PTECs following HFD treatment (Yamamoto et al., 2017; Sun et al., 2020). These results suggested that HFD may impair renal function.
High-fat diet can also induce the destruction of the renal proximal tubular structure (Luo et al., 2019). Studies have reported an increase in vacuole number in mouse renal PTECs, accompanied by impaired brush border and epithelial cell shedding, following HFD treatment (Declèves et al., 2014; Li et al., 2016; Sun et al., 2020). Following HFD treatment, mouse renal PTEC vacuoles were found to contain multilamellar, onion skin-like structures (Declèves et al., 2014; Kuwahara et al., 2016; Yamamoto et al., 2017). In addition, several studies have reported the filling of PTECs with lipid droplets following HFD treatment (Hao et al., 2012; Szeto et al., 2016; Muller et al., 2019). These results indicate that HFD induces lipid accumulation and vacuolar degeneration in PTECs. HFD can also induce epithelial cell detachment, tubular dilatation, and tubulointerstitial extracellular matrix accumulation (Hao et al., 2012; Takagi et al., 2018). HFD-induced renal proximal tubular injury occurs mainly in the S1 and S2 renal tubules, and this may be related to the fact that these tubules are rich in mitochondria, lysosomes, and other organelles (Declèves et al., 2014).
In addition, HFD was found to be associated with significant disorganization of the cytoplasm and mitochondrial damage (Szeto et al., 2016; Takagi et al., 2018). These mitochondria appeared small and round, were in constant fission, and had no cristae membranes as opposed to those in cells of mice fed with normal diet (Szeto et al., 2016; Sun et al., 2020).
Interestingly, the adverse impact of maternal exposure to HFD on the kidneys of offspring has been confirmed by some studies (Nguyen et al., 2019; Shamseldeen et al., 2019; Larkin et al., 2021). Chowdhury et al. (2016) reported that in rats, paternal exposure to HFD could lead to renal lipid accumulation, loss of brush border, and increased cell sloughing in adult offspring; however, these effects were mild. Further studies are needed to determine whether HFD induces alterations in the kidneys of offspring.
Palmitic Acid-Induced Renal Tubular Epithelial Cell Lesions in vitro
Many studies have shown that treatment with SFAs, especially palmitic acid (PA), can damage cultured human PTECs (HK-2 cells; Xie et al., 2017; Yamamoto et al., 2017; Qiu et al., 2018). Endoplasmic reticulum (ER) stress, increased lipid deposition, cell apoptosis, and an elevated inflammatory response have been observed in PA-treated HK-2 cells (Wu et al., 2019; Mai et al., 2020). Furthermore, PA-treated rat PTECs (NRK-52E cells) showed a significant increase in the levels of cleaved caspase-3, which is significantly associated with apoptosis (Cobbs et al., 2019). In addition, a significant increase and decrease in mitochondrial reactive oxygen species (ROS) and mitochondrial oxidative phosphorylation gene mRNA levels, respectively, were observed in PA-treated PTECs, confirming that HFD could induce mitochondrial injury (Yamamoto et al., 2017). Moreover, cell survival was found to be decreased in HFD-treated renal PTECs (Yamamoto et al., 2017). These findings provided evidence of the harmfulness of HFD in renal PTECs; however, the molecular mechanisms underlying this is unclear.
HFD-Induced Renal Tubular Inflammatory Injury and Its Potential Underlying Mechanisms
Chronic inflammation and lipid abnormalities are important synergistic factors that induce pathological changes in the kidneys (Wang et al., 2018). Aside from playing a vital role in reabsorption, renal PTECs also function as inflammatory cells and release various pro-inflammatory cytokines in response to injury (Liu et al., 2018). Many recent studies have shown that HFD triggers renal PTEC injury, accompanied by monocyte infiltration and the release of inflammatory signaling molecules, such as interleukin (IL-1β, IL-6), tumor necrosis factor alpha (TNFα), transforming growth factor β1 (TGF-β1), chemokines, such as monocyte chemotactic protein 1 (MCP-1), and IL-8 (Kim et al., 2013; Szeto et al., 2016; Yamamoto et al., 2017; Yang et al., 2017; Wang et al., 2017b; Hewage et al., 2020). Inflammatory cytokines protect the renal tubules from damage during the early stages of injury (Meng et al., 2014), while chronic inflammatory infiltration may damage the structure and function of renal tubules at an advanced stage, subsequently causing renal tubular fibrosis (Meng, 2019). Furthermore, HFD-induced excessive SFA accumulation (especially PA, which accounts for 80–90% of SFAs) in renal PTECs can stimulate the production of pro-inflammatory cytokines and adhesion molecules, and induce the activation of the nuclear factor kappa B (NF-κB) signaling pathway, thus causing renal tubular dysfunction and inflammatory damage (Huang et al., 2012; Fang et al., 2017). Long-term pro-inflammatory cytokines infiltration can induce TIF progression. The specific signaling pathways involved in inflammation and tubular lipid toxicity, which may be related to the inflammatory pathways below (Figure 1), need to be further elucidated. Various studies indicated that several signaling pathways including oxidative stress-related signaling pathways, mitochondrial dysfunction-related signaling pathways, the myeloid differentiation molecule 2 (MD2)-toll-like receptor 4 (TLR4) signaling pathways, the ERK1/2-KIM-1-related pathways, and NF-κB activation were involved in HFD-induced renal inflammatory injury.
Figure 1. The potential mechanisms of HFD-induced renal proximal tubular epithelial cell inflammatory injury. (1) HFD promotes the generation of pro-inflammatory molecules by stimulating the MD2-TLR4 complex to recruit MyD88; (2) HFD-induced mitochondrial dysfunction is related to mitochondrial FAO impairment, mitophagy deficiency, and dynamic change; (3) KIM-1 may be upregulated by HFD-activated ERK1/2, and promotes the release of pro-inflammatory molecules directly or indirectly through the mTOR-related pathway; (4) HFD induces NF-κB activation via different pathways (e.g., miRNAs), and subsequently upregulates the expression of pro-inflammatory cytokines; and (5) Oxidative stress participate in HFD-induced PTEC inflammatory injury via different pathways. HFD, high-fat diet; MD2-TLR4, myeloid differentiation molecule 2–toll like receptor 4; MyD88, myeloid differentiation primary response protein 88; FAO, fatty acid oxidation; KIM-1, kidney injury molecule 1; ERK1/2, extracellular signal-regulated kinase 1/2; mTOR, mammalian target of rapamycin; NF-κB, nuclear factor-κB; and miRNAs, micro RNAs.
Oxidative Stress-Related Signaling Pathways
As known, oxidative stress is detrimental to cells due to the ROS and reactive nitrogen species (RNS) overproduction. To date, many studies have suggested that HFD-induced oxidative stress is detrimental to kidney (Arany et al., 2016; Mei et al., 2020; Sun et al., 2020).
High-fat diet significantly promote the production of ROS and inflammatory response such as NLRP3 activation and the release of many inflammatory cytokines in kidney (Morris et al., 2009; Yamamoto et al., 2017; Weihong et al., 2019; Zheng et al., 2019b; Sun et al., 2020). The production of ROS is the critical event of oxidative stress (Muthulakshmi and Saravanan, 2013), which plays a key role in the pathogenesis of CKD (Daenen et al., 2019; Neelofar et al., 2019). HFD-induced oxidative stress in renal tubules is characterized by the increased production of ROS and NADPH oxidase such as oxidative stress marker Gp91, and thus promote the cytochrome C release from mitochondria to cytoplasm (Sun et al., 2020).
Moreover, recent studies confirmed that ROS may lead to the inflammatory injury of renal tubules in HFD (Song et al., 2018; Rehman et al., 2019; Zheng et al., 2019b; Eleazu et al., 2020). A study showed that the inhibition of ROS production may block the secretion of pro-inflammatory cytokines via inhibiting NF-κB signal pathway (Rehman et al., 2019). Another study showed that HFD-induced renal tubular inflammatory injury and oxidative stress is associated with iRhom2/NF-κB and Nrf-2/HO-1 signaling pathways (Chenxu et al., 2021). Furthermore, HFD-induced renal injury is related to the expression of NADHP oxidase, which may active ROS-mediated NLRP3 inflammasome and NF-κB/p38 signaling pathway (Song et al., 2018). In addition, HFD may cause oxidative stress and renal proximal tubular injury through IL-33/ST2 signal pathway (Elsherbiny et al., 2020). The upregulated expression of HFD-induced vascular endothelial growth factor receptor-2 (VEGFR2) in the kidney may induces NLRP3-dependent inflammatory responses via increasing ROS production (Zheng et al., 2019b). CCR2-knockout may improve renal injury through inhibiting oxidative stress and ER stress in HFD (Lee et al., 2019). TNF-α deficiency also can downregulate the oxidative stress and inflammation of proximal tubular cells in HFD (Wang et al., 2017a). Collectively, these results indicated that HFD-induced oxidative stress may lead to the renal injury via different signal pathways.
In summary, the production of ROS is involved in the pathogenesis of renal inflammatory injury-induced by HFD, and ROS target therapy can significantly inhibit dyslipidemia and improve renal inflammatory injury.
Mitochondrial Dysfunction
As known, mitochondria mainly provide ATP and energy to maintain cellular homeostasis and regulate the communication between cells and tissues. Recent studies showed that mitochondria play an important role in HFD-induced renal inflammatory injury (Sun et al., 2020; Han et al., 2021; Lubojemska et al., 2021). Mitochondrial dysfunction-induced by HFD is related to mitochondrial fatty acid oxidative (FAO) impairment, dynamic change (e.g., mitochondrial fission and fusion) and mitophagy deficiency.
Insufficient mitochondrial FAO in renal resident cells is thought to be responsible for HFD-induced kidney injury (Xu et al., 2014; Kang et al., 2015; Lv et al., 2019). Previous studies have found that HFD could lead to mitochondrial FAO dysfunction and promote the expression of transforming growth factor beta 1 (TGFβ1; Wang et al., 2018; Lv et al., 2019). TGFβ1 was found to be an important upstream regulator of FA metabolism in PTECs (Kang et al., 2015). These findings show that FAO impairment is involved in HFD-induced renal PTEC injury.
Long-term lipid overload may lead to phospholipid accumulation and inadequate acidification in lysosomal system of PTECs, stagnates autophagic flux, subsequently resulting in the deficiency of renal tubular autophagy (Yamamoto et al., 2017). The production of ROS in mitochondria is increased significantly and the ratio of mitochondrial DNA/nuclear DNA is decreased significantly in PTECS with autophagy deficiency, and thus induce inflammatory response (Yamamoto et al., 2017). For the molecular mechanisms involved in this progress, Unc-51-like autophagy activating kinase 1 (ULK1) has been confirmed to be inactivated in HFD-induced renal injury (Declèves et al., 2011, 2014; Sohn et al., 2017; Luo et al., 2019). More important, the recovery of mitophagy deficiency can attenuate HFD-induced renal tubular inflammatory injury (Han et al., 2021). In addition, mitochondrial dynamic changes were also reported in HFD (Chen et al., 2018; Sun et al., 2020).
Collectively, these findings show that FAO impairment, mitophagy deficiency and mitochondrial dynamic changes play pathogenic roles in HFD-induced renal inflammatory injury.
The MD2-TLR4 Signaling Pathway
Toll-like receptor 4 is a pattern recognition receptor and an important innate immune regulator that stimulates innate immune responses by binding to a series of infectious agent-associated ligands, such as the MD2, which is an important pathogenic factor that contributes to inflammatory injury, and is required for TLR4 activation (Takeuchi and Akira, 2010; Huang et al., 2012; Rocha et al., 2016). MD2 initially binds to the cell surface ligand and then induces the activation of the MD2-TLR4 immune signaling complex (Wang et al., 2017b). Data indicated that the MD2-TLR4 complex is a key pathogenic agent in the progression of obesity-related nephropathy (Xu et al., 2019). Several recent studies have shown that HFD induces MD2 expression and promotes the formation of the MD2-TLR4 complex in renal tissues, thereby causing inflammation and injury in PTECs (Fang et al., 2017; Xu et al., 2019; Zhang et al., 2020a). MD2 inhibition or knockout was found to prevent SFA-induced renal PTEC inflammation and injury. However, the specific target of the MD2-TLR4 signaling pathway-mediated HFD-induced renal tubular inflammatory injury still needs to be determined. Moreover, many studies suggested that FFAs induces NF-κB to promote the release of pro-inflammatory cytokines (e.g., TNFα, IL-6, and IL1β) by stimulating the MD2-TLR4 complex to recruit myeloid differentiation primary response protein 88 (MyD88; Rocha et al., 2016; Wang et al., 2017b; Song et al., 2021). However, whether this pathway participates in lipid nephrotoxicity remains to be further verified.
Oxidized low-density lipoprotein (ox-LDL), which is metabolized to 9-hydroxyoctadecenoic acid and 13-octadecenoic acid, is an important biomarker of oxidative lipid damage, and activates the peroxisome proliferator-activated receptor γ (PPARγ), a transcription factor involved in adipogenesis (Gai et al., 2019). This implies that ox-LDL may mediate tissue oxidative damage by activating transcription factors associated with lipid production. HFD significantly promotes ox-LDL generation. Xu et al. (2019) initially reported that ox-LDL-induced MD2-mediated TLR4 activation induces PTEC lesions in rats, and that the inhibition of MD2 blockade effectively prevents ox-LDL- and HFD-induced lesions. This is a new discovery as concerns the potential factors involved in HFD-induced renal injury. In addition, PA induces the generation of pro-inflammatory cytokines by stimulating the MD2-TLR4 complex to recruit MyD88, which is primarily associated with FFA-induced inflammatory responses (Rocha et al., 2016; Wang et al., 2017b). Data has shown that three PA molecules bind to the MD2 capsule with a relatively high affinity to form a stable complex (Wang et al., 2017b). MD2 also binds to unsaturated fatty acids, but can only induce a pro-inflammatory response when it binds to SFAs (Wang et al., 2017b).
Therefore, it is necessary to understand how MD2 regulates ox-LDL-induced proximal tubule injury as this could provide a new reference for CKD treatment. However, there are few relevant studies on the subject, and this study was only conducted on cells, and findings thereof need to be further verified through animal experiments.
The ERK1/2-KIM-1-Related Pathway
Kidney injury molecule 1, a type 1 transmembrane protein, is a sensitive proximal tubular injury marker (Han et al., 2002; Humphreys et al., 2013), which is expressed during PTEC impairment (van Timmeren et al., 2006; Ichimura et al., 2008; Gauer et al., 2016). HFD stimulates KIM-1 expression in PTECs and induces an increase in KIM-1-regulated proximal tubular inflammation and cell damage (Zhao et al., 2019), and this is a new discovery as far as lipid nephrotoxicity is concerned.
Studies have shown that KIM-1 protects the kidneys from further injury by regulating PTEC phagocytosis and through its anti-inflammatory effects during the early stages of kidney injury (Ichimura et al., 2008; Yang et al., 2015). However, KIM-1 overexpression may induce inflammation and interstitial fibrosis in renal tubules (van Timmeren et al., 2007; Humphreys et al., 2013; Lin et al., 2014). KIM-1 can be detected in large quantities in the plasma and urine samples of diabetic patients, and this may be correlated with the occurrence and development of early DN (Nowak et al., 2016). Researchers found that SFA accumulation can stimulate inflammation and KIM-1 overexpression in PTECs in vitro (Zhao et al., 2019). Therefore, KIM-1 may be significantly associated with lipid toxicity-induced inflammation and tubular injury. They further confirmed that KIM-1 was upregulated through extracellular signal-regulated kinase 1/2 (ERK1/2) activation, and promoted the expression of injury-related molecules such as osteopontin (OPN) and CD44, and cysteine aspartic protease 3; KIM-1 inhibition was found to alleviate PA-induced proximal tubular injury (Zhao et al., 2019). This study provided a new direction for the study of lipid nephrotoxicity. A study carried out in zebrafish models showed that sustained KIM-1 expression in proximal tubules induces the activation of the mammalian target of rapamycin pathway (mTOR), which mediates the loss of tubular brush border, subsequently triggering inflammation and the occurrence and progression of chronic kidney disease (Yin et al., 2016). Therefore, renal injury-induced by HFD-mediated KIM-1 upregulation may also be involved in the activation of the mTOR pathway.
Although many studies have confirmed that KIM-1 is related to kidney injury, the molecular mechanisms underlying the KIM-1-specific signaling pathway-mediated HFD-induced proximal tubular inflammatory injury, which leads to CKD, is yet to be elucidated.
NF-κB Activation
Nuclear factor kappa B, which is composed of a series of transcription factors, is highly expressed in almost all cells, and can be activated by pro-inflammatory cytokines, such as TNF-α and IL-1 (Bonizzi and Karin, 2004; Pflug and Sitcheran, 2020). Its downstream target genes include IL-1β, IL-6, and TNFα, which play a pivotal role in regulating the inflammatory response (Oeckinghaus and Ghosh, 2009). In general, NF-κB activity is inhibited by the inhibitor of NF-κB proteins (IκBs) in the cytoplasm. NF-κB disintegrates and regulates nuclear transfer when exposed to external stimuli, thereby acting as a transcription factor and promoting the expression of various pro-inflammatory cytokines (Oeckinghaus and Ghosh, 2009).
It has been reported that NF-κB expression levels significantly increase in renal tubular cells following HFD treatment (Li et al., 2020); this subsequently induces an upregulation of the expression levels of pro-inflammatory cytokines such as IL-6 and TNFα (Hewage et al., 2020). Moreover, many studies have shown that in mice, NF-κB inhibition protects the kidneys from HFD-induced injury (Fang et al., 2015; Eleazu et al., 2020). However, it is still unclear which signaling pathways regulate the inflammatory response in HFD-induced renal tubular inflammation. A recent study showed that HFD promoted the releases of circulating pro-inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6, and MCP-1), and enhanced the PTEC inflammation by activating NF-κB/histone deacetylase 3 (NF-κB/HDAC3) signaling pathway (Li et al., 2021).
Recently, miRNAs were reported that may significantly associated with the HFD-induced chronic renal inflammatory response (Sun et al., 2019; Zheng et al., 2019a). miR-155 was reported to participate in HFD-induced renal inflammatory and injury via the regulation of SHIP1/NF-κB signaling pathway (Zheng et al., 2019a). MiR-802 can regulate the renal inflammatory injury in HFD mice by directly suppressing the NF-κB-repressing factor (NRF; Sun et al., 2019). Furthermore, HFD-induced renal tubular inflammatory injury can be attenuated by inhibiting the secretion of exosomes from renal PTECs by targeting the miR-26a-5p/CHAC1/NF-κB pathway (Li et al., 2020).
At present, the role of miRNAs in NF-κB activation in HFD-induced renal tubular inflammatory still need further study. However, we believe that with the rapid advancements in technological platforms such as cell sequencing technology, great progress will be made in this field; this would help provide important data and information to improve our understanding of HFD-induced CKD pathogenesis and allow for the development of an effective intervention strategy for the disease.
Future Perspectives
The prevalence of HFD is increasing rapidly worldwide, and the injury of renal tubules induced by HFD strongly associated with CKD. It has been well-known that inflammation plays a crucial role in the injury of renal tubule-induced by HFD; however, the specific molecular mechanisms involved in this progress have not yet been well identified to date, although they may include several signaling pathways (e.g., oxidative stress signaling pathways, NF-κB activation). Therefore, potential therapies target these pathways may hold promise for the treatment of HFD-induced CKD. Here, we summarize the novel insights into the mechanisms of HFD-induced renal tubular inflammatory injury in HFD-induced CKD, and promising therapeutic strategies, which may help improve the understanding of the pathogenesis of CKD and provide novel therapies for CKD.
Author Contributions
SC, JC, SL, and QiP wrote the manuscript and designed the figures. SC, FG, AL, HW, JC, QuP, SL, and H-fL revised the manuscript. All authors contributed to the article and approved the submitted version.
Funding
This study was supported by National Natural Science Foundation of China (no. 82070757), the Project of “Dengfeng Plan” and Department of established positions for the Zhujiang Scholar from Guangdong Medical University, and Guangdong Basic and Applied Basic Research Foundation (no. 2019A1515012203), and the Zhanjiang City Program for Tackling Key Problems in Science and Technology (no. 2019B01179).
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Agrawal, S., Zaritsky, J. J., Fornoni, A., and Smoyer, W. E. (2018). Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. Nat. Rev. Nephrol. 14, 57–70. doi: 10.1038/nrneph.2017.155
Arany, I., Hall, S., Reed, D. K., Reed, C. T., and Dixit, M. (2016). Nicotine enhances high-fat diet-induced oxidative stress in the kidney. Nicotine Tob. Res. 18, 1628–1634. doi: 10.1093/ntr/ntw029
Arici, M., Chana, R., Lewington, A., Brown, J., and Brunskill, N. J. (2003). Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-gamma. J. Am. Soc. Nephrol. 14, 17–27. doi: 10.1097/01.ASN.0000042167.66685.EA
Balaban, R. S., and Mandel, L. J. (1988). Metabolic substrate utilization by rabbit proximal tubule. An NADH fluorescence study. Am. J. Physiol. 254, F407–F416. doi: 10.1152/ajprenal.1988.254.3.F407
Bermudez-Lopez, M., Forne, C., Amigo, N., Bozic, M., Arroyo, D., Bretones, T., et al. (2019). An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients. Expert Opin. Ther. Targets 23, 619–630. doi: 10.1080/14728222.2019.1620206
Bikbov, C. P. B., Levey, A. S., Smith, M., Abdoli, A., Abebe, O. M. A. M., Afarideh, M., et al. (2020). Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet 395, 709–733. doi: 10.1016/S0140-6736(20)30045-3
Birn, H., and Christensen, E. I. (2006). Renal albumin absorption in physiology and pathology. Kidney Int. 69, 440–449. doi: 10.1038/sj.ki.5000141
Bobulescu, I. A. (2010). Renal lipid metabolism and lipotoxicity. Curr. Opin. Nephrol. Hypertens. 19, 393–402. doi: 10.1097/MNH.0b013e32833aa4ac
Bonizzi, G., and Karin, M. (2004). The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280–288. doi: 10.1016/j.it.2004.03.008
Brunskill, N. J., Nahorski, S., and Walls, J. (1997). Characteristics of albumin binding to opossum kidney cells and identification of potential receptors. Pflugers Arch. 433, 497–504. doi: 10.1007/s004240050305
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., et al. (2016). 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur. Heart J. 37, 2999–3058. doi: 10.1093/eurheartj/ehw272
Chen, Y., He, L., Yang, Y., Chen, Y., Song, Y., Lu, X., et al. (2019). The inhibition of Nrf2 accelerates renal lipid deposition through suppressing the ACSL1 expression in obesity-related nephropathy. Ren. Fail. 41, 821–831. doi: 10.1080/0886022X.2019.1655450
Chen, D., Li, X., Zhang, L., Zhu, M., and Gao, L. (2018). A high-fat diet impairs mitochondrial biogenesis, mitochondrial dynamics, and the respiratory chain complex in rat myocardial tissues. J. Cell. Biochem. 119:9602. doi: 10.1002/jcb.27068
Cheng, K., Song, Z., Chen, Y., Li, S., Zhang, Y., Zhang, H., et al. (2019). Resveratrol protects against renal damage via attenuation of inflammation and oxidative stress in high-fat-diet-induced obese mice. Inflammation 42, 937–945. doi: 10.1007/s10753-018-0948-7
Chenxu, G., Xianling, D., Qin, K., Linfeng, H., Yan, S., Mingxin, X., et al. (2021). Fisetin protects against high fat diet-induced nephropathy by inhibiting inflammation and oxidative stress via the blockage of iRhom2/NF-κB signaling. Int. Immunopharmacol. 92:107353. doi: 10.1016/j.intimp.2020.107353
Chowdhury, S. S., Lecomte, V., Erlich, J. H., Maloney, C. A., and Morris, M. J. (2016). Paternal high fat diet in rats leads to renal accumulation of lipid and tubular changes in adult offspring. Nutrients 8:521. doi: 10.3390/nu8090521
Cobbs, A., Chen, X., Zhang, Y., George, J., Huang, M. B., Bond, V., et al. (2019). Saturated fatty acid stimulates production of extracellular vesicles by renal tubular epithelial cells. Mol. Cell. Biochem. 458, 113–124. doi: 10.1007/s11010-019-03535-6
Czaplińska, M., Ćwiklińska, A., Sakowicz-Burkiewicz, M., Wieczorek, E., Kuchta, A., Kowalski, R., et al. (2019). Apolipoprotein E gene polymorphism and renal function are associated with apolipoprotein E concentration in patients with chronic kidney disease. Lipids Health Dis. 18:60. doi: 10.1186/s12944-019-1003-x
Daenen, K., Andries, A., Mekahli, D., Van Schepdael, A., Jouret, F., and Bammens, B. (2019). Oxidative stress in chronic kidney disease. Pediatr. Nephrol. 34, 975–991. doi: 10.1007/s00467-018-4005-4
de Vries, A. P., Ruggenenti, P., Ruan, X. Z., Praga, M., Cruzado, J. M., Bajema, I. M., et al. (2014). Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. Lancet Diabetes Endocrinol. 2, 417–426. doi: 10.1016/S2213-8587(14)70065-8
Declèves, A. E., Mathew, A. V., Cunard, R., and Sharma, K. (2011). AMPK mediates the initiation of kidney disease induced by a high-fat diet. J. Am. Soc. Nephrol. 22, 1846–1855. doi: 10.1681/ASN.2011010026
Declèves, A. E., Zolkipli, Z., Satriano, J., Wang, L., Nakayama, T., Rogac, M., et al. (2014). Regulation of lipid accumulation by AMP-activated kinase [corrected] in high fat diet-induced kidney injury. Kidney Int. 85, 611–623. doi: 10.1038/ki.2013.462
Ding, Y., Tan, Y., Qu, Z., and Yu, F. (2020). Renal microvascular lesions in lupus nephritis. Ren. Fail. 42, 19–29. doi: 10.1080/0886022X.2019.1702057
Dong, Y., Zhang, Q., Wen, J., Chen, T., He, L., Wang, Y., et al. (2019). Ischemic duration and frequency determines AKI-to-CKD progression monitored by dynamic changes of tubular biomarkers in IRI mice. Front. Physiol. 10:153. doi: 10.3389/fphys.2019.00153
Eleazu, C., Suleiman, J. B., Othman, Z. A., Zakaria, Z., Nna, V. U., Hussain, N. H. N., et al. (2020). Bee bread attenuates high fat diet induced renal pathology in obese rats via modulation of oxidative stress, downregulation of NF-kB mediated inflammation and bax signalling. Arch. Physiol. Biochem. 22, 1–17. doi: 10.1080/13813455.2020.1752258
Elsherbiny, N. M., Said, E., Atef, H., and Zaitone, S. A. (2020). Renoprotective effect of calycosin in high fat diet-fed/STZ injected rats: effect on IL-33/ST2 signaling, oxidative stress and fibrosis suppression. Chem. Biol. Interact. 315:108897. doi: 10.1016/j.cbi.2019.108897
Fang, Q., Deng, L., Wang, L., Zhang, Y., Weng, Q., Yin, H., et al. (2015). Inhibition of mitogen-activated protein kinases/nuclear factor κB-dependent inflammation by a novel chalcone protects the kidney from high fat diet-induced injuries in mice. J. Pharmacol. Exp. Ther. 355, 235–246. doi: 10.1124/jpet.115.226860
Fang, Q., Wang, L., Yang, D., Chen, X., Shan, X., Zhang, Y., et al. (2017). Blockade of myeloid differentiation protein 2 prevents obesity-induced inflammation and nephropathy. J. Cell. Mol. Med. 21, 3776–3786. doi: 10.1111/jcmm.13287
Gai, Z., Wang, T., Visentin, M., Kullak-Ublick, G. A., Fu, X., and Wang, Z. (2019). Lipid accumulation and chronic kidney disease. Nutrients 11:722. doi: 10.3390/nu11040722
Gao, Y., Zhang, W., Zeng, L. Q., Bai, H., Li, J., Zhou, J., et al. (2020). Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy. Redox Biol. 36:101635. doi: 10.1016/j.redox.2020.101635
Gauer, S., Urbschat, A., Gretz, N., Hoffmann, S. C., Kränzlin, B., Geiger, H., et al. (2016). Kidney injury molecule-1 is specifically expressed in cystically-transformed proximal tubules of the PKD/Mhm (cy/+) rat model of polycystic kidney disease. Int. J. Mol. Sci. 17:802. doi: 10.3390/ijms17060802
Gong, Y., Li, G., Tao, J., Wu, N. N., Kandadi, M. R., Bi, Y., et al. (2020). Double knockout of Akt2 and AMPK accentuates high fat diet-induced cardiac anomalies through a cGAS-STING-mediated mechanism. Biochim. Biophys. Acta Mol. Basis Dis. 1866:165855. doi: 10.1016/j.bbadis.2020.165855
Gullans, S. R., Brazy, P. C., Mandel, L. J., and Dennis, V. W. (1984). Stimulation of phosphate transport in the proximal tubule by metabolic substrates. Am. J. Physiol. 247, F582–F587. doi: 10.1152/ajprenal.1984.247.4.F582
Hager, M. R., Narla, A. D., and Tannock, L. R. (2017). Dyslipidemia in patients with chronic kidney disease. Rev. Endocr. Metab. Disord. 18, 29–40. doi: 10.1007/s11154-016-9402-z
Hagve, T. A., Narce, M., Tjønneland, S. E., Odden, N., Liabø, J., and Poisson, J. P. (2001). Desaturation and esterification of fatty acids in kidney cells from spontaneously hypertensive rats. Scand. J. Clin. Lab. Invest. 61, 151–159. doi: 10.1080/00365510151097683
Han, W. K., Bailly, V., Abichandani, R., Thadhani, R., and Bonventre, J. V. (2002). Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 62, 237–244. doi: 10.1046/j.1523-1755.2002.00433.x
Han, Y. C., Tang, S. Q., Liu, Y. T., Li, A. M., Zhan, M., Yang, M., et al. (2021). AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice. Cell Death Dis. 12:925. doi: 10.1038/s41419-021-04184-8
Hao, J., Liu, S. X., Zhao, S., Liu, Q. J., Liu, W., and Duan, H. J. (2012). High-fat diet causes increased serum insulin and glucose which synergistically lead to renal tubular lipid deposition and extracellular matrix accumulation. Br. J. Nutr. 107, 74–85. doi: 10.1017/S0007114511002613
Herman-Edelstein, M., Scherzer, P., Tobar, A., Levi, M., and Gafter, U. (2014). Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy. J. Lipid Res. 55, 561–572. doi: 10.1194/jlr.P040501
Hewage, S. M., Prashar, S., Debnath, S. C., and Siow, Y. L. (2020). Inhibition of inflammatory cytokine expression prevents high-fat diet-induced kidney injury: role of lingonberry supplementation. Front. Med. 7:80. doi: 10.3389/fmed.2020.00080
Hill, N. R., Fatoba, S. T., Oke, J. L., Hirst, J. A., O'Callaghan, C. A., Lasserson, D. S., et al. (2016). Global prevalence of chronic kidney disease—a systematic review and meta-analysis. PLoS One 11:e0158765. doi: 10.1371/journal.pone.0158765
Hohos, N. M., and Skaznik-Wikiel, M. E. (2017). High-fat diet and female fertility. Endocrinology 158, 2407–2419. doi: 10.1210/en.2017-00371
Huang, S., Rutkowsky, J. M., Snodgrass, R. G., Ono-Moore, K. D., Schneider, D. A., Newman, J. W., et al. (2012). Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J. Lipid Res. 53, 2002–2013. doi: 10.1194/jlr.D029546
Humphreys, B. D., Xu, F., Sabbisetti, V., Grgic, I., Naini, S. M., Wang, N., et al. (2013). Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis. J. Clin. Invest. 123, 4023–4035. doi: 10.1172/JCI45361
Ichimura, T., Asseldonk, E. J., Humphreys, B. D., Gunaratnam, L., Duffield, J. S., and Bonventre, J. V. (2008). Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J. Clin. Invest. 118, 1657–1668. doi: 10.1172/JCI34487
Joven, J., Villabona, C., Vilella, E., Masana, L., Albertí, R., and Vallés, M. (1990). Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome. N. Engl. J. Med. 323, 579–584. doi: 10.1056/NEJM199008303230905
Juszczak, F., Caron, N., Mathew, A. V., and Declèves, A. E. (2020). Critical role for AMPK in metabolic disease-induced chronic kidney disease. Int. J. Mol. Sci. 21:7994. doi: 10.3390/ijms21217994
Kang, H. M., Ahn, S. H., Choi, P., Ko, Y. A., Han, S. H., Chinga, F., et al. (2015). Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat. Med. 21, 37–46. doi: 10.1038/nm.3762
Kennedy, D. J., Chen, Y., Huang, W., Viterna, J., Liu, J., Westfall, K., et al. (2013). CD36 and Na/K-ATPase-α1 form a proinflammatory signaling loop in kidney. Hypertension 61, 216–224. doi: 10.1161/HYPERTENSIONAHA.112.198770
Khan, S., Jawdeh, B. G. A., Goel, M., Schilling, W. P., Parker, M. D., Puchowicz, M. A., et al. (2014). Lipotoxic disruption of NHE1 interaction with PI(4,5)P2 expedites proximal tubule apoptosis. J. Clin. Invest. 124, 1057–1068. doi: 10.1172/JCI71863
Kim, D., Lee, J. E., Jung, Y. J., Lee, A. S., Lee, S., Park, S. K., et al. (2013). Metformin decreases high-fat diet-induced renal injury by regulating the expression of adipokines and the renal AMP-activated protein kinase/acetyl-CoA carboxylase pathway in mice. Int. J. Mol. Med. 32, 1293–1302. doi: 10.3892/ijmm.2013.1508
Kiss, E., Kränzlin, B., Wagenblaβ, K., Bonrouhi, M., Thiery, J., Gröne, E., et al. (2013). Lipid droplet accumulation is associated with an increase in hyperglycemia-induced renal damage: prevention by liver X receptors. Am. J. Pathol. 182, 727–741. doi: 10.1016/j.ajpath.2012.11.033
Kopin, L., and Lowenstein, C. (2017). Dyslipidemia. Ann. Intern. Med. 167, ITC81–ITC96. doi: 10.7326/aitc201712050
Kuwahara, S., Hosojima, M., Kaneko, R., Aoki, H., Nakano, D., Sasagawa, T., et al. (2016). Megalin-mediated tubuloglomerular alterations in high-fat diet-induced kidney disease. J. Am. Soc. Nephrol. 27, 1996–2008. doi: 10.1681/ASN.2015020190
Lamprea-Montealegre, J. A., McClelland, R. L., Grams, M., Ouyang, P., Szklo, M., and de Boer, I. H. (2018). Coronary heart disease risk associated with the dyslipidaemia of chronic kidney disease. Heart 104, 1455–1460. doi: 10.1136/heartjnl-2017-312794
Larkin, B. P., Saad, S., Glastras, S. J., Nguyen, L. T., Hou, M., Chen, H., et al. (2021). Low-dose hydralazine during gestation reduces renal fibrosis in rodent offspring exposed to maternal high fat diet. PLoS One 16:e0248854. doi: 10.1371/journal.pone.0248854
Lee, S. J., Kang, J. S., Kim, H. M., Lee, E. S., Lee, J. H., Chung, C. H., et al. (2019). CCR2 knockout ameliorates obesity-induced kidney injury through inhibiting oxidative stress and ER stress. PLoS One 14:e0222352. doi: 10.1371/journal.pone.0222352
Li, Q., Ge, C., Tan, J., Sun, Y., Kuang, Q., Dai, X., et al. (2021). Juglanin protects against high fat diet-induced renal injury by suppressing inflammation and dyslipidemia via regulating NF-κB/HDAC3 signaling. Int. Immunopharmacol. 95:107340. doi: 10.1016/j.intimp.2020.107340
Li, S., Jia, Y., Xue, M., Hu, F., Zheng, Z., Zhang, S., et al. (2020). Inhibiting Rab27a in renal tubular epithelial cells attenuates the inflammation of diabetic kidney disease through the miR-26a-5p/CHAC1/NF-kB pathway. Life Sci. 261:118347. doi: 10.1016/j.lfs.2020.118347
Li, C., Lin, Y., Luo, R., Chen, S., Wang, F., Zheng, P., et al. (2016). Intrarenal renin-angiotensin system mediates fatty acid-induced ER stress in the kidney. Am. J. Physiol. Ren. Physiol. 310, F351–F363. doi: 10.1152/ajprenal.00223.2015
Lin, Q., Chen, Y., Lv, J., Zhang, H., Tang, J., Gunaratnam, L., et al. (2014). Kidney injury molecule-1 expression in IgA nephropathy and its correlation with hypoxia and tubulointerstitial inflammation. Am. J. Physiol. Ren. Physiol. 306, F885–F895. doi: 10.1152/ajprenal.00331.2013
Liu, Y., Coresh, J., Eustace, J. A., Longenecker, J. C., Jaar, B., Fink, N. E., et al. (2004). Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA 291, 451–459. doi: 10.1001/jama.291.4.451
Liu, B. C., Tang, T. T., Lv, L. L., and Lan, H. Y. (2018). Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int. 93, 568–579. doi: 10.1016/j.kint.2017.09.033
Lubojemska, A., Stefana, M. I., Sorge, S., Bailey, A. P., Lampe, L., Yoshimura, A., et al. (2021). Adipose triglyceride lipase protects renal cell endocytosis in a Drosophila dietary model of chronic kidney disease. PLoS Biol. 19:e3001230. doi: 10.1371/journal.pbio.3001230
Luo, Y., Wu, M. Y., Deng, B. Q., Huang, J., Hwang, S. H., Li, M. Y., et al. (2019). Inhibition of soluble epoxide hydrolase attenuates a high-fat diet-mediated renal injury by activating PAX2 and AMPK. Proc. Natl. Acad. Sci. U. S. A. 116, 5154–5159. doi: 10.1073/pnas.1815746116
Lv, T., Hu, Y., Ma, Y., Zhen, J., Xin, W., and Wan, Q. (2019). GCN5L1 controls renal lipotoxicity through regulating acetylation of fatty acid oxidation enzymes. J. Physiol. Biochem. 75, 597–606. doi: 10.1007/s13105-019-00711-6
Lv, J. C., and Zhang, L. X. (2019). Prevalence and disease burden of chronic kidney disease. Adv. Exp. Med. Biol. 1165, 3–15. doi: 10.1007/978-981-13-8871-2_1
Mai, X., Yin, X., Chen, P., and Zhang, M. (2020). Salvianolic acid B protects against fatty acid-induced renal tubular injury via inhibition of endoplasmic reticulum stress. Front. Pharmacol. 11:574229. doi: 10.3389/fphar.2020.574229
Mei, Y., Kuai, Y., Hu, H., Liu, F., Liu, B., Sun, X., et al. (2020). Isosteviol sodium attenuates high fat/high cholesterol-induced kidney dysfunction by inhibiting inflammation, oxidative stress and apoptosis. Biol. Pharm. Bull. 43, 1172–1178. doi: 10.1248/bpb.b19-01028
Meng, X. M. (2019). Inflammatory mediators and renal fibrosis. Adv. Exp. Med. Biol. 1165, 381–406. doi: 10.1007/978-981-13-8871-2_18
Meng, X. M., Nikolic-Paterson, D. J., and Lan, H. Y. (2014). Inflammatory processes in renal fibrosis. Nat. Rev. Nephrol. 10, 493–503. doi: 10.1038/nrneph.2014.114
Miljkovic, M., Stefanovic, A., Simic-Ogrizovic, S., Vekic, J., Bogavac-Stanojevic, N., Cerne, D., et al. (2018). Association of dyslipidemia, oxidative stress, and inflammation with redox status in VLDL, LDL, and HDL lipoproteins in patients with renal disease. Angiology 69, 861–870. doi: 10.1177/0003319718780041
Moorhead, J. F., Chan, M. K., El-Nahas, M., and Varghese, Z. (1982). Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 2, 1309–1311. doi: 10.1016/s0140-6736(82)91513-6
Moreno, J. A., Gomez-Guerrero, C., Mas, S., Sanz, A. B., Lorenzo, O., Ruiz-Ortega, M., et al. (2018). Targeting inflammation in diabetic nephropathy: a tale of hope. Expert Opin. Investig. Drugs 27, 917–930. doi: 10.1080/13543784.2018.1538352
Morris, E. M., Whaley-Connell, A. T., Thyfault, J. P., Britton, S. L., Koch, L. G., Wei, Y., et al. (2009). Low aerobic capacity and high-fat diet contribute to oxidative stress and IRS-1 degradation in the kidney. Am. J. Nephrol. 30, 112–119. doi: 10.1159/000204362
Muller, C. R., Leite, A. P. O., Yokota, R., Pereira, R. O., Americo, A. L. V., Nascimento, N. R. F., et al. (2019). Post-weaning exposure to high-fat diet induces kidney lipid accumulation and function impairment in adult rats. Front. Nutr. 6:60. doi: 10.3389/fnut.2019.00060
Muthulakshmi, S., and Saravanan, R. (2013). Protective effects of azelaic acid against high-fat diet-induced oxidative stress in liver, kidney and heart of C57BL/6J mice. Mol. Cell. Biochem. 377, 23–33. doi: 10.1007/s11010-013-1566-1
Neelofar, K., Arif, Z., Arafat, M. Y., Alam, K., and Ahmad, J. (2019). A study on correlation between oxidative stress parameters and inflammatory markers in type 2 diabetic patients with kidney dysfunction in north Indian population. J. Cell. Biochem. 120, 4892–4902. doi: 10.1002/jcb.27763
Nguyen, L. T., Mak, C. H., Chen, H., Zaky, A. A., Wong, M. G., Pollock, C. A., et al. (2019). SIRT1 attenuates kidney disorders in male offspring due to maternal high-fat diet. Nutrients 11:146. doi: 10.3390/nu11010146
Nowak, N., Skupien, J., Niewczas, M. A., Yamanouchi, M., Major, M., Croall, S., et al. (2016). Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes. Kidney Int. 89, 459–467. doi: 10.1038/ki.2015.314
Oeckinghaus, A., and Ghosh, S. (2009). The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol. 1:a000034. doi: 10.1101/cshperspect.a000034
Pflug, K. M., and Sitcheran, R. (2020). Targeting NF-κB-inducing kinase (NIK) in immunity, inflammation, and cancer. Int. J. Mol. Sci. 21:8470. doi: 10.3390/ijms21228470
Qiu, M., Li, S., Jin, L., Feng, P., Kong, Y., Zhao, X., et al. (2018). Combination of chymostatin and aliskiren attenuates ER stress induced by lipid overload in kidney tubular cells. Lipids Health Dis. 17:183. doi: 10.1186/s12944-018-0818-1
Rabinovich-Nikitin, I., Dhingra, R., and Kirshenbaum, L. A. (2019). Activation of mitophagy in high-fat diet-induced diabetic cardiomyopathy. Circ. Res. 124, 1288–1290. doi: 10.1161/CIRCRESAHA.119.314967
Rahman, M., Yang, W., Akkina, S., Alper, A., Anderson, A. H., Appel, L. J., et al. (2014). Relation of serum lipids and lipoproteins with progression of CKD: the CRIC study. Clin. J. Am. Soc. Nephrol. 9, 1190–1198. doi: 10.2215/cjn.09320913
Rapa, S. F., Di Iorio, B. R., Campiglia, P., Heidland, A., and Marzocco, S. (2019). Inflammation and oxidative stress in chronic kidney disease-potential therapeutic role of minerals, vitamins and plant-derived metabolites. Int. J. Mol. Sci. 21:263. doi: 10.3390/ijms21010263
Rehman, M. U., Rashid, S. M., Rasool, S., Shakeel, S., Ahmad, B., Ahmad, S. B., et al. (2019). Zingerone (4-(4-hydroxy-3-methylphenyl)butan-2-one) ameliorates renal function via controlling oxidative burst and inflammation in experimental diabetic nephropathy. Arch. Physiol. Biochem. 125, 201–209. doi: 10.1080/13813455.2018.1448422
Rocha, D. M., Caldas, A. P., Oliveira, L. L., Bressan, J., and Hermsdorff, H. H. (2016). Saturated fatty acids trigger TLR4-mediated inflammatory response. Atherosclerosis 244, 211–215. doi: 10.1016/j.atherosclerosis.2015.11.015
Rohr, M. W., Narasimhulu, C. A., Rudeski-Rohr, T. A., and Parthasarathy, S. (2020). Negative effects of a high-fat diet on intestinal permeability: a review. Adv. Nutr. 11, 77–91. doi: 10.1093/advances/nmz061
Ruiz-Ortega, M., Rayego-Mateos, S., Lamas, S., Ortiz, A., and Rodrigues-Diez, R. R. (2020). Targeting the progression of chronic kidney disease. Nat. Rev. Nephrol. 16, 269–288. doi: 10.1038/s41581-019-0248-y
Schaeffner, E. S., Kurth, T., Curhan, G. C., Glynn, R. J., Rexrode, K. M., Baigent, C., et al. (2003). Cholesterol and the risk of renal dysfunction in apparently healthy men. J. Am. Soc. Nephrol. 14, 2084–2091. doi: 10.1681/ASN.V1482084
Schaffer, J. E. (2002). Fatty acid transport: the roads taken. Am. J. Physiol. Endocrinol. Metab. 282, E239–E246. doi: 10.1152/ajpendo.00462.2001
Schaffer, J. E. (2003). Lipotoxicity: when tissues overeat. Curr. Opin. Lipidol. 14, 281–287. doi: 10.1097/00041433-200306000-00008
Shamseldeen, A. M., Eshra, M. A., Rashed, L. A., Amer, M. F., Fares, A. E., and Kamar, S. S. (2019). Omega-3 attenuates high fat diet-induced kidney injury of female rats and renal programming of their offsprings. Arch. Physiol. Biochem. 125, 367–377. doi: 10.1080/13813455.2018.1471511
Sohn, M., Kim, K., Uddin, M. J., Lee, G., Hwang, I., Kang, H., et al. (2017). Delayed treatment with fenofibrate protects against high-fat diet-induced kidney injury in mice: the possible role of AMPK autophagy. Am. J. Physiol. Ren. Physiol. 312, F323–F334. doi: 10.1152/ajprenal.00596.2015
Song, M., Meng, L., Liu, X., and Yang, Y. (2021). Feprazone prevents free fatty acid (FFA)-induced endothelial inflammation by mitigating the activation of the TLR4/MyD88/NF-κB pathway. ACS Omega 6, 4850–4856. doi: 10.1021/acsomega.0c05826
Song, W., Wei, L., Du, Y., Wang, Y., and Jiang, S. (2018). Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice. Int. Immunopharmacol. 63, 227–238. doi: 10.1016/j.intimp.2018.07.027
Stremmel, W., Pohl, L., Ring, A., and Herrmann, T. (2001). A new concept of cellular uptake and intracellular trafficking of long-chain fatty acids. Lipids 36, 981–989. doi: 10.1007/s11745-001-0809-2
Sun, D., Chen, J., Wu, W., Tang, J., Luo, L., Zhang, K., et al. (2019). MiR-802 causes nephropathy by suppressing NF-κB-repressing factor in obese mice and human. J. Cell. Mol. Med. 23, 2863–2871. doi: 10.1111/jcmm.14193
Sun, Y., Ge, X., Li, X., He, J., Wei, X., Du, J., et al. (2020). High-fat diet promotes renal injury by inducing oxidative stress and mitochondrial dysfunction. Cell Death Dis. 11:914. doi: 10.1038/s41419-020-03122-4
Szeto, H. H., Liu, S., Soong, Y., Alam, N., Prusky, G. T., and Seshan, S. V. (2016). Protection of mitochondria prevents high-fat diet-induced glomerulopathy and proximal tubular injury. Kidney Int. 90, 997–1011. doi: 10.1016/j.kint.2016.06.013
Takagi, S., Li, J., Takagaki, Y., Kitada, M., Nitta, K., Takasu, T., et al. (2018). Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high-fat diet. J. Diabetes Investig. 9, 1025–1032. doi: 10.1111/jdi.12802
Takeuchi, O., and Akira, S. (2010). Pattern recognition receptors and inflammation. Cell 140, 805–820. doi: 10.1016/j.cell.2010.01.022
van Timmeren, M. M., Bakker, S. J., Vaidya, V. S., Bailly, V., Schuurs, T. A., Damman, J., et al. (2006). Tubular kidney injury molecule-1 in protein-overload nephropathy. Am. J. Physiol. Ren. Physiol. 291, F456–F464. doi: 10.1152/ajprenal.00403.2005
van Timmeren, M. M., van den Heuvel, M. C., Bailly, V., Bakker, S. J., van Goor, H., and Stegeman, C. A. (2007). Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J. Pathol. 212, 209–217. doi: 10.1002/path.2175
Vaziri, N. D. (2016). HDL abnormalities in nephrotic syndrome and chronic kidney disease. Nat. Rev. Nephrol. 12, 37–47. doi: 10.1038/nrneph.2015.180
Wang, Z., Huang, W., Li, H., Tang, L., Sun, H., Liu, Q., et al. (2018). Synergistic action of inflammation and lipid dysmetabolism on kidney damage in rats. Ren. Fail. 40, 175–182. doi: 10.1080/0886022X.2018.1450763
Wang, H., Li, J., Gai, Z., Kullak-Ublick, G. A., and Liu, Z. (2017a). TNF-α deficiency prevents renal inflammation and oxidative stress in obese mice. Kidney Blood Press. Res. 42, 416–427. doi: 10.1159/000478869
Wang, Y., Qian, Y., Fang, Q., Zhong, P., Li, W., Wang, L., et al. (2017b). Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2. Nat. Commun. 8:13997. doi: 10.1038/ncomms13997
Wang, V., Vilme, H., Maciejewski, M. L., and Boulware, L. E. (2016). The economic burden of chronic kidney disease and end-stage renal disease. Semin. Nephrol. 36, 319–330. doi: 10.1016/j.semnephrol.2016.05.008
Webster, A. C., Nagler, E. V., Morton, R. L., and Masson, P. (2017). Chronic kidney disease. Lancet 389, 1238–1252. doi: 10.1016/S0140-6736(16)32064-5
Weihong, C., Bin, C., and Jianfeng, Y. (2019). Transmembrane protein 126B protects against high fat diet (HFD)-induced renal injury by suppressing dyslipidemia via inhibition of ROS. Biochem. Biophys. Res. Commun. 509, 40–47. doi: 10.1016/j.bbrc.2018.12.003
Wu, Y., Chen, F., Huang, X., Zhang, R., Yu, Z., Chen, Z., et al. (2019). Berberine (BBR) attenuated palmitic acid (PA)-induced lipotoxicity in human HK-2 cells by promoting peroxisome proliferator-activated receptor α (PPAR-α). Med. Sci. Monit. 25, 7702–7708. doi: 10.12659/MSM.916686
Xie, X., Yi, W., Zhang, P., Wu, N., Yan, Q., Yang, H., et al. (2017). Green tea polyphenols, mimicking the effects of dietary restriction, ameliorate high-fat diet-induced kidney injury via regulating autophagy flux. Nutrients 9:497. doi: 10.3390/nu9050497
Xu, Y., Huang, J., Xin, W., Chen, L., Zhao, X., Lv, Z., et al. (2014). Lipid accumulation is ahead of epithelial-to-mesenchymal transition and therapeutic intervention by acetyl-CoA carboxylase 2 silence in diabetic nephropathy. Metabolism 63, 716–726. doi: 10.1016/j.metabol.2014.02.010
Xu, S., Luo, W., Xu, X., Qian, Y., Xu, Z., Yu, W., et al. (2019). MD2 blockade prevents oxLDL-induced renal epithelial cell injury and protects against high-fat-diet-induced kidney dysfunction. J. Nutr. Biochem. 70, 47–55. doi: 10.1016/j.jnutbio.2019.04.003
Yamamoto, T., Takabatake, Y., Minami, S., Sakai, S., Fujimura, R., Takahashi, A., et al. (2021). Eicosapentaenoic acid attenuates renal lipotoxicity by restoring autophagic flux. Autophagy 17, 1700–1713. doi: 10.1080/15548627.2020.1782034
Yamamoto, T., Takabatake, Y., Takahashi, A., Kimura, T., Namba, T., Matsuda, J., et al. (2017). High-fat diet-induced lysosomal dysfunction and impaired autophagic flux contribute to lipotoxicity in the kidney. J. Am. Soc. Nephrol. 28, 1534–1551. doi: 10.1681/ASN.2016070731
Yang, L., Brooks, C. R., Xiao, S., Sabbisetti, V., Yeung, M. Y., Hsiao, L. L., et al. (2015). KIM-1-mediated phagocytosis reduces acute injury to the kidney. J. Clin. Invest. 125, 1620–1636. doi: 10.1172/JCI75417
Yang, P., Xiao, Y., Luo, X., Zhao, Y., Zhao, L., Wang, Y., et al. (2017). Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice. J. Lipid Res. 58, 1417–1427. doi: 10.1194/jlr.M076216
Yin, W., Naini, S. M., Chen, G., Hentschel, D. M., Humphreys, B. D., and Bonventre, J. V. (2016). Mammalian target of rapamycin mediates kidney injury molecule 1-dependent tubule injury in a surrogate model. J. Am. Soc. Nephrol. 27, 1943–1957. doi: 10.1681/ASN.2015050500
Zhang, Y., Chen, H., Zhang, W., Cai, Y., Shan, P., Wu, D., et al. (2020a). Arachidonic acid inhibits inflammatory responses by binding to myeloid differentiation factor-2 (MD2) and preventing MD2/toll-like receptor 4 signaling activation. Biochim. Biophys. Acta Mol. Basis Dis. 1866:165683. doi: 10.1016/j.bbadis.2020.165683
Zhang, Y., Ecelbarger, C. M., Lesniewski, L. A., Müller, C. E., and Kishore, B. K. (2020b). P2Y(2) receptor promotes high-fat diet-induced obesity. Front. Endocrinol. 11:341. doi: 10.3389/fendo.2020.00341
Zhao, X., Chen, X., Zhang, Y., George, J., Cobbs, A., Wang, G., et al. (2019). Kidney injury molecule-1 is upregulated in renal lipotoxicity and mediates palmitate-induced tubular cell injury and inflammatory response. Int. J. Mol. Sci. 20:3406. doi: 10.3390/ijms20143406
Zheng, G. H., Shan, Q., Mu, J. J., Wang, Y. J., Zhang, Z. F., Fan, S. H., et al. (2019b). Purple sweet potato color attenuates kidney damage by blocking VEGFR2/ROS/NLRP3 signaling in high-fat diet-treated mice. Oxid. Med. Cell. Longev. 2019:5189819. doi: 10.1155/2019/5189819
Zheng, C., Zhang, J., Chen, X., Zhang, J., Ding, X., You, X., et al. (2019a). MicroRNA-155 mediates obesity-induced renal inflammation and dysfunction. Inflammation 42, 994–1003. doi: 10.1007/s10753-019-00961-y
Keywords: high-fat diet, renal proximal tubules, inflammation, mechanisms, chronic kidney disease, dyslipidemia
Citation: Chen S, Chen J, Li S, Guo F, Li A, Wu H, Chen J, Pan Q, Liao S, Liu H-f and Pan Q (2021) High-Fat Diet-Induced Renal Proximal Tubular Inflammatory Injury: Emerging Risk Factor of Chronic Kidney Disease. Front. Physiol. 12:786599. doi: 10.3389/fphys.2021.786599
Edited by:
Hui Y. Lan, The Chinese University of Hong Kong, ChinaCopyright © 2021 Chen, Chen, Li, Guo, Li, Wu, Chen, Pan, Liao, Liu and Pan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hua-feng Liu, bGl1aGZAZ2RtdS5lZHUuY24=; Qingjun Pan, cHFqQGdkbXUuZWR1LmNu
†These authors have contributed equally to this work and share first authorship